Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for May 2010
May 3, 2010
- BioSante Pharmaceuticals Announces Reinitiation of Prostate Cancer Vaccine Development
- Targacept and AstraZeneca Agree to Expanded TC-5619 Development Program
- FDA Embraces Pozen's Arthritis Drug
- Auxilium Pares 1Q Loss As Testim Sales Grow
- Suit: HPV Vaccine Injured Teen
- Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
May 4, 2010
- FDA Orders Recall of Baxter Infusion Pumps
- Boehringer Ingelheim Gets Time For CFC-Free Inhaler
- Copaxone Sales, Lower Charges Lift Teva First Quarter Profit
- FDA Drug Safety Communication: Ongoing Safety Review of GnRH Agonists and Possible Increased Risk of Diabetes and Certain Cardiovascular Diseases
- Pharmasset Affirms Safety and Continued Progress in Clinical Development of RG7128
- Pfizer Reports First-Quarter 2010 Results; Reaffirms 2010 Financial Guidance
- Merck Announces First-Quarter 2010 Financial Results
- NAI Published In Applied Clinical Trials On Strategic Uses Of Safety Monitoring Data
- Copaxone Sales, Lower Charges Lift Teva 1q Profit
- Risk of Suicide, Suicide Attempt Similar Across Types of Antidepressant Medication
- Wyeth Seeks New Nev. Trial In Hormone Drugs Case
- FDA Challenged by HiFi DNA Tech to Provide Proof That HPV Types 6 & 11 Cause Vulvar and Vaginal Cancers
May 5, 2010
- FDA Rejects Intermune Lung Drug; Seeks More Trial Data
- Novartis to Pay $72.5 Million to Settle False Claims Suit
- King Pharmaceuticals Reports First-Quarter 2010 Financial Results
- PharmaLive Examines Drugs And Devices In Development For Diabetes ? A Worldwide Epidemic
- Merck Acquires Development and Commercialization Rights to Investigational mTOR Inhibitor Ridaforolimus from ARIAD Pharmaceuticals, Inc.
- FDA Sends Warning Letter to Novartis Regarding Websites
- FDA Warns Glaxo on Altabax Promotion
- Rising Clinical Trial Complexity Continues to Vex Drug Developers
May 6, 2010
- Sanofi-Aventis Canada Cuts Nearly 70 Jobs
- Sanofi-Aventis Canada Cuts Nearly 70 Jobs
- Jury Finds Drug Makers Liable In Hepatitic C Case
- Utah AG Sues Over Marketing Of Drugs: State Seeks To Recover Money For Promoting Illegal Uses Of Medications
- Town Sues Pharmaceutical Company Over Loan
- FDA Sends Genentech Warning Letter Over Rituxan Promotion
- FDA Sends Shire Letter Regarding Lialda Promotion
- Pfizer and AstraZenca Take Top Slots on First Digital IQ Index for Pharma Brands
- Merck Wins Second Federal Fosamax (alendronate sodium) Bellwether Trial
May 7, 2010
- Genzyme Oks $2B Buyback, Mulls Options For 3 Units
- Amylin Faces Oct. 22 FDA Review For Bydureon drug
- FDA Approves Bayer Oral Contraceptive
- Doctor Won't See You Mr. Pharma Rep, say ZS Associates AccessMonitor
- Lilly Plans 200 Sales, Marketing Job Cuts
May 10, 2010
- Teva Plans Appeal of Hepatitis Verdict: Jury Awarded Man $356 Million in Lawsuit
- Publicis Groupe Announces its Acquisition From Dentsu Inc. of 7,500,000 of its Own Shares in Order to Cancel Them
- Vaccines and Related Biological Products Advisory Committee Meeting Briefing Document
- Takeda to Co-Promote Velcade (bortezomib) for Injection in Japan
May 11, 2010
- Avexa Closes Apricitabine (Atc) Program
- Merck Highlights Robust Late-Stage Pipeline, Global Business Strategy and Progress of Integration
- Studies Document Risks Associated With Common Acid-Suppressing Medications
- Parkinson's Disease Treatments Associated With Compulsive Behaviors
- SDI Reports: Pharmaceutical Promotional Spending Indicates Trend Toward Electronic and Online Promotion
- Gilead Announces $5 Billion Share Repurchase Program
- Glaxo Extends Asia Push With Dong-A Alliance
- GSK Extends Presence In Asia With New Strategic Alliance in South Korea
- Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy for Growth in Emerging Markets
May 12, 2010
- FDA: ?Bad Ad Program? to Help Health Care Providers Detect, Report Misleading Drug Ads
- Status Quo in Healthcare Is Not an Option: Health Reform May Make Health Organizations' Current Business Practices and Markets Irrelevant, says PricewaterhouseCoopers
- 2010-2012 Mid-Range Plan - Transformation for a New Takeda
- Daiichi Sankyo Announces New Executive Candidates
- Pfizer Enters Into Agreement With Ergonex Pharma to Acquire Investigational Treatment for Pulmonary Arterial Hypertension
- Abbott Laboratories Signs Licensing Deal With Zydus Cadila
May 13, 2010
- PharmaLive Releases Analysis Of Pharma Industry DTC Advertising Spend By Brand, Company, And Media
- Brazil Challenges EU Generic Drugs Seizures At WTO
May 14, 2010
- New Large Study Results Confirm Safety Profile of Zostavax, Merck's Shingles Vaccine, in People Aged 60 or Older
- Pharmagap Shares Drop On Heavy Trading Amid Cancer Drug Test Results
- Strides and Pfizer Strengthen Partnership
- Ahead Of The Bell: Pozen Upgraded
- FDA Denial of Teva Petition Might Be Good News for Momenta
- Biovest Files Plan of Reorganization
May 17, 2010
- Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
- FDA says Healthcare Providers Can Resume Use of Rotarix (Rotavirus Vaccine, Live, Oral)
- Halozyme Delivers Notice of Breach to Baxter Healthcare Due to Hylenex Manufacturing Failures
- Army's Use Of Controversial Drug Eyed
- Despite Test Results, FDA Urges Vaccine Use
- Federal Agents Probing Army's Use Of Trauma Drug: Criminal Investigation Looking At Military's Use Of Blood-Clotting Injections For Treating War Casualties
- Amgen Seeks Cancer Approval For Bone Loss Drug
- Japan's Astellas To Buy US Drug Co. OSI For $4 Bln
- Voluntary Recall Of Hylenex Initiated
May 18, 2010
- INC Set For Growth In Raleigh
- AARP Report Finds Largest Brand Name Drug Price Spike in Eight Years While General Inflation Remains Near Zero
- Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network
- Pfizer Partners With University to Develop New Uses for Drugs
- AstraZeneca Reaches US Agreement With Teva Pharmaceuticals Regarding Entocort EC Capsules
May 19, 2010
- Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of All Lots of Metronidazole Injection, USP 500 mg/100 mL
- Roche and Biogen Idec Announce Their Decision to Discontinue the ocrelizumab Clinical Development Programme in Patients with Rheumatoid Arthritis
- Javelin Pharmaceuticals, Inc. Comments on Tender Offer Extension by Hospira
- After Cuts, Roche Says It's Growing
- Lilly Endowment Value Slips
- Novartis To Appeal Sex Discrimination Case
- Indian Piramal Denies Reports On Sale Talks
- FDA Transparency Task Force Unveils Draft Proposals on Agency Disclosure Policies
- Teva Announces Launch and Shipment of Generic Lipitor® Tablets in Canada
May 20, 2010
- Jury Awards Novartis Women $250 Million
- New Research: Kids' Consumption of Chronic Medications on the Rise
May 21, 2010
- Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare Solutions Business
- Scientists Create First Living Synthetic Cell With Computer, Mix Of Chemicals
- Some statins have unintended effects and warrant closer monitoring, study finds
- Ortho-McNeil Pharmaceutical, LLC Pleads Guilty to Illegal Promotion of Topamax and is Sentenced to Criminal Fine of $6.14 Million
- Contract Pharmaceuticals closing upstate NY plant
- Prescription drug-coupon plan passes House, heads to Senate
- Celldex shares fall following study update
May 25, 2010
- FDA and NIH Launch Electronic Safety Reporting Portal
- CDER Statement to Healthcare Professionals: Restricted Availability of Thyrogen
- Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits
- Britain Bans Doctor Who Linked Autism To Vaccine
- Astellas Announces New Mid-Term Management Plan
- Genzyme Announces Final Terms of FDA Consent Decree
- Novartis Announces Extension of US Regulatory Priority Review Period for FTY720, an Investigational Once-daily Oral Multiple Sclerosis Therapy
May 26, 2010
- FDA Announces Collaboration with Drugs.com
- FDA Sends Amgen Letter Regarding Vectibix Oral Statements
- FDA Drug Safety Communication: Possible Increased Risk of Fractures of the Hip, Wrist, and Spine with the Use of Proton Pump Inhibitors
- Watson Sued By Genzyme Over Generic Renvela Plans
- Actor Dennis Quaid Sues Drug Maker Over Newborn twins' Overdoses on Heparin
- Sanofi-aventis Establishes Strategic Alliance with MIT's Center for Biomedical Innovation
- Ultram (tramadol hydrochloride), Ultracet (tramadol hydrochloride/acetaminophen): Label Change
- Stem Cell Therapeutics Corp. Announces Top-Line Results for the Modified Regenesis Phase IIb Stroke Trial
- Liver Cancer Drug Not Recommended for the NHS
- GTx Announces Top Line Results of Phase III Clinical Trial Evaluating Toremifene 20 mg for the Prevention of Prostate Cancer in Men with High Grade PIN
- Podcast Series From Med Ad News Magazine Explores Closed-Loop Marketing
- Genzyme to Pay $175M For Manufacturing Problems
- Martin Mackay to Lead AstraZeneca's Research and Development Organisation
- GSK Consumer Healthcare to Update alli Label as FDA Completes Safety Review of Orlistat
